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      A twenty-two year old woman, investigated because of tetanic convulsion and ref-
ractory hypocalcemia, was shown to have hypomagnesemia, hypokalemia, hypocalciuria 
and hypophosphaturia. The patient sometimes had loose stool but no steatorrhea. Bowel 
absorption test of D-Xylose, 131I-triolein and 47Ca were in the normal range. Relative 
hypermagnesuria was observed despite of hypomagnesemia. Renal function was normal. 
Parathyroid hormone level was quite low but showed a rapid increase after the injection 
of magnesium supplement. Normal responsiveness to parathyroid hormone was observed 
in the kidney. Oral administration of magnesium supplement resulted in relief of sub-
jective symptoms as well as normal serum levels of calcium and potassium. During this 
period, serum magnesium rose up but never reached the normal level. These findings 
suggested that renal magnesium wastage of unknown etiology was the significant factor 
contributing to the hypomagnesemia and that hypocalcemia was probable due to impaired 
serection of PTH. The mechanism of the hypokalemia observed with the magnesium 
depletion remains unknown.
                  INTRODUCTION 
     A decreased serum level of magnesium may accompany a considerable number of 
pathologic conditions. Hypomagnesemia of unknown etiology, however, is unusual2>s>i3). 
The present communication deals with a 22 year old woman who was found to have pri-
mary renal wastage of magnesium. Hypocalcemia and hypokalemia are well-recognized 
manifestation of magnesium deficiency')"). The pathophysiologic mechanism of these con-
ditions are discussed.
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                   CASE REPORT 
     A 22-year-old woman was admitted to the hospital because of tetany and generalized 
convulsion in September 1977. There was parental consanguinity ; they were first cousins. 
She was born at a normal delivery. Her parents, two sisters and brother didn't have 
tetany or hypomagnesemia. Since weaning, she had had frequent loose stools. At age of 
11 and 14, she had suffered generalized convulsions. At age of 20, hypocalcemia was 
found. Despite calcium administration, she had frequent tetany and refractory hypocal-
cemia. She had stiff hands virtually all day. 
     On admission, she was 139 cm in height and 42 kg in weight. Chvostek's sign and 
Trousseau's sign were positive. The remainder of the physical examination was normal. 
Proteinuria, hematuria and aminoaciduria were not observed. The Fishberg urine con-
centration test and phenolsulfonphthalein test were within the normal range. Steatorrhea 
was not observed. Serum calcium, phosphorus, and potassium were 7.9 mg/dl, 3.2 mg/d 
and 3.5 mEq/L respectively. BUN was 6.0 mg/dl. Creatinine was 0.4 mg/dl. Creatinine 
clearance was 114 ml/min. Urinary excretion of calcium and phosphorus on an ordinary 
diet were 20-60 mg/day and 30-400 mg/day respectively. Potassium clearance was 11.4 
ml/min. No abnormalities were found on bone X-ray films, G-I series, Ba enema, and 
C. T. scanning of the pancreas. Bowel absorption tests were normal on 131I-triolein, D-
Xylose, and 47Ca. Pancreozymin-Secretin test was normal. No abnormalities were found 
in Arginine infusion test, TRH test, LH-RH test and rapid ACTH test. 
     Calcium gluconate was administered intravenously to improve tetany and hypocal-
cemia. Clinical symptoms were relieved temporarily but hypocalcemia didn't improve with 
it. On the other hand, hypomagnesemia with inappropriately high excretion of magnesium 
in urine and low PTH level despite hypocalcemia were observed. Magnesium sulfate 
(10 mEq) was drip-infused intravenously. The serum PTH level was 0.2 ng/ml before 
magnesium administration (normal range :0.5-1.0 ng/ml). At 15 minutes after the initi-
ation of magnesium infusion, PTH rose up to 0.7 ng/ml. Serum calcium level during 
this test showed slight decrease (Fig. 1). The Ellsworth-Howard test was performed. 
Bovine PTH (200 units) was injected intramuscularly. Cyclic AMP/creatinine and phos-
phorus/creatinine in urine responded with a 130 times increase and a 4.6 times increase 
respectively (Fig. 2). 
     Oral therapy was started with 25 mEq of magnesium sulfate and the dose was 
gradually increased up to 90 mEq a day. Serum magnesium rose only to subnormal values. 
Serum calcium and potassium also returned to normal with this magnesium supplement. 
Magnesium excretion in the urine reached as much as 300 mg a day although the serum 
magnesium remained subnormal. However, her clinical condition improved and she only 
had stiff hands occasionally (Fig. 3).
Fig. 1 Magnesium infusion induced a tem-
      porary increase in serum PTH level 
      which was initially low. Serum calcium 
      showed a slight decrease at that time.
Fig. 2 Excretion of c-AMP and phosphorus in 
      urine increased normally after the admi-
      nistration of bovine PTH 200 unit.
Fig. 3 Serum magnesium level rose only to subnormal values despite supplemental 
       administration of magnesium while urinary excretion of magnesium increased 
       during it. Serum calcium level was normalized by magnesium supplement 
       alone.
                    DISCUSSION 
     Hypomagnesemia has been described in association with many disease state, for 
example : malabsorption syndrome, hyperaldosteronism, primary hyperparathyroidisrn, 
chronic alcoholism, hyperthyroidism, and various malignancies. In our case, ordinary 
renal function tests were normal and renal loss of potassium, sodium, calcium and phos-
phorus were not observed. Urinary excretion of magnesium was, however, inappropriately 
high despite hypomagnesemia. Large dose of magnesium supplement didn't normalize 
serum magnesium completely and high excretion of magnesium in the urine continued. 
The mechanism of renal magnesium wastage remained unexplained. Though evidence of 
malabsorption, steatorrhea and intestinal protein loosing were not demonstrated, she had 
loose stool frequently. This situation might worsen the hypomagnesemia and induce tetany. 
We considered that the main cause of hypomagnesemia in this patient was primary renal 
magnesium wastage though an accurate balance study of magnesium was not performed. 
     Hypocalcemia is well known in magnesium deficiency. Many investigators have 
suggested mechanism involving parathyroid hormone in the hypocalcemia of magnesium 
depletion. Some investigators suggested end-organ unresponsiveness to PTH10314) and some 
an impaired production and/or secretion of PTH1)3'4>11>ls). Others considered both mech-
anisms') . In our case, responsiveness to PTH in the kidney was normal ;excretion of 
c-AMP and phosphorus in the urine in the Ellsworth-Howard test was normal. Serum 
PTH was quite low despite of hypocalcemia but responded to acute magnesium adminis-
tration. These findings suggested.that secretion of PTH was reduced but the capacity to 
produce it was maintained. Magnesium therapy normalized serum calcium and potassium 
levels without any other supplements. Thus magnesium ion was found necessary for normal 
calcium and potassium homeostasis. Temporary hypocalcemia after magnesium infusion 
was also observed in our case. It has been well documented that the parenteral adminis-
tration of magnesium reduces serum calcium, partly through a calciuric effect and possibly 
by causing a shift of calcium into cell"". ANASTI) considered that the early fall in serum 
calcium was due to a shift of extracellular calcium into cells, produced by an increase in 
either parat.1iyroid hormone or magnesium or both ; the decline in serum calcium observed 
after infusion of magnesium was too rapid to be accounted for by an increase in urinary 
calcium. 
     Hypokalemia is a well-recognized manifestation of magnesium deficiency. Our case 
also showed hypokalemia which was normalized by magnesium administration. We cannot 
currently explain the mechanism of this hypokalemia. 
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